Literature DB >> 8592637

Hypothalamic blood flow remains unaltered following chronic nitric oxide synthase blockade in rats.

Z Benyó1, C Szabó, B T Stuiver, B Bohus, P Sándor.   

Abstract

The effect of the chronic oral application of NG-nitro-L-arginine methyl ester (L-NAME), a potent inhibitor of nitric oxide (NO) production, was studied on hypothalamic blood flow (HBF) and hypothalamic nitric oxide synthase (NOS) activity in rats. L-NAME was dissolved in the drinking water, in a concentration of 0.1 mg/ml, and was administered for 1 week. In the chronic L-NAME pretreated animals significantly reduced hypothalamic NOS activity and marked hypothalamic vasoconstriction were observed, the latter of which was counteracted by sustained systemic arterial hypertension, while HBF remained unchanged. The present model of chronic NOS blockade may be useful to assess the physiological functions of NO in the regulation of cerebral blood flow in the normally perfused brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592637     DOI: 10.1016/0304-3940(95)11981-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Adaptation of the hypothalamic blood flow to chronic nitric oxide deficiency is independent of vasodilator prostanoids.

Authors:  László Hortobágyi; Béla Kis; András Hrabák; Béla Horváth; Gergely Huszty; Horst Schweer; Balázs Benyó; Péter Sándor; David W Busija; Zoltán Benyó
Journal:  Brain Res       Date:  2006-12-11       Impact factor: 3.252

2.  Hypersensitivity to thromboxane receptor mediated cerebral vasomotion and CBF oscillations during acute NO-deficiency in rats.

Authors:  Béla Horváth; Gábor Lenzsér; Balázs Benyó; Tamás Németh; Rita Benko; András Iring; Péter Hermán; Katalin Komjáti; Zsombor Lacza; Péter Sándor; Zoltán Benyó
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

Review 3.  Production, regulation and role of nitric oxide in glial cells.

Authors:  V A Vincent; F J Tilders; A M Van Dam
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.